Treatment of neuromyelitis optica: Review and recommendations

Treatment of neuromyelitis optica: Review and recommendations

Taispeáin leaganacha eile (1)

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2012

Míreanna comhchosúla

Treatment of Neuromyelitis Optica: Review and Recommendations.
de réir: Kimbrough, D, et al.
Foilsithe / Cruthaithe: (2012)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
de réir: Jyh Yung Hor, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
de réir: Pittock, S, et al.
Foilsithe / Cruthaithe: (2019)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
de réir: Fujihara, K, et al.
Foilsithe / Cruthaithe: (2014)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
de réir: Collongues, N, et al.
Foilsithe / Cruthaithe: (2013)

The borderland of neuromyelitis optica.
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2009)

Neuromyelitis optica associated with systemic autoimmune diseases in children
de réir: Russo RA, et al.
Foilsithe / Cruthaithe: (2008-09-01)

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
de réir: Mealy, M, et al.
Foilsithe / Cruthaithe: (2014)

Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
de réir: Douglas Kazutoshi Sato, et al.
Foilsithe / Cruthaithe: (2014-06-01)

Atypical presentations of neuromyelitis optica
de réir: Douglas Sato, et al.
Foilsithe / Cruthaithe: (2011-10-01)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
de réir: Kim, W, et al.
Foilsithe / Cruthaithe: (2012)

Use of mitoxantrone in neuromyelitis optica.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2011)

Current and future treatment approaches for neuromyelitis optica
de réir: Nicolas Collongues, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Treatment of neuromyelitis optica: an evidence based review
de réir: Douglas Sato, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
de réir: Sung-Min Kim, et al.
Foilsithe / Cruthaithe: (2017-07-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2015)

Magnetic resonance imaging in neuromyelitis optica.
de réir: Tackley, G, et al.
Foilsithe / Cruthaithe: (2014)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
de réir: Nicolas Collongues, et al.
Foilsithe / Cruthaithe: (2016-05-01)

Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort
de réir: Shervin Gholizadeh, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
de réir: Cree, BAC, et al.
Foilsithe / Cruthaithe: (2019)

A practical guide to the treatment of neuromyelitis optica.
de réir: Palace, J, et al.
Foilsithe / Cruthaithe: (2012)

The evolving clinical spectrum of neuromyelitis optica
de réir: Viegas, S, et al.
Foilsithe / Cruthaithe: (2008)

A mathematical model of cellular swelling in Neuromyelitis optica
de réir: Laranjeira, S, et al.
Foilsithe / Cruthaithe: (2017)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
de réir: Sato, D, et al.
Foilsithe / Cruthaithe: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
de réir: Matthews, L, et al.
Foilsithe / Cruthaithe: (2013)

Neuromyelitis Optica
de réir: Goyal V, et al.
Foilsithe / Cruthaithe: (2009-10-01)

Neuromyelitis optica
de réir: Jacob Anu, et al.
Foilsithe / Cruthaithe: (2007-01-01)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2015)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
de réir: Lucy Matthews, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
de réir: Romain Marignier, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
de réir: Viegas, S, et al.
Foilsithe / Cruthaithe: (2009)

Seasonal pattern of variation in neuromyelitis optica relapses
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
de réir: Jarius, S, et al.
Foilsithe / Cruthaithe: (2007)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
de réir: Luppe, S, et al.
Foilsithe / Cruthaithe: (2012)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
de réir: Laurie Baert, et al.
Foilsithe / Cruthaithe: (2021-08-01)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
de réir: Achim Berthele, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Racial differences in neuromyelitis optica spectrum disorder
de réir: Kim, S, et al.
Foilsithe / Cruthaithe: (2018)